Company news
Invo Fertility, Inc. (NASDAQ:IVF) news
Invo Fertility, Inc. news releases on 6ix. Latest, Feb 3, 2022: INVO Bioscience Expands U.S. Commercialization Efforts
Press releases — page 3
INVO Bioscience Expands U.S. Commercialization Efforts
February 2, 2022
INVO Bioscience Enters into Agreement with Ovoclinic in Spain to Expand INVOcell Commercialization
December 15, 2021
INVO Bioscience to Participate in the Lytham Partners Winter 2021 Investor Conference
December 9, 2021
INVO Bioscience Obtains Regulatory Approval to Commercialize INVOcell In Thailand
November 30, 2021
INVO Bioscience Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update
November 14, 2021
INVO Bioscience Regains Full U.S. Commercialization Rights
November 7, 2021
INVO Bioscience Announces Four Individual Poster Abstracts Discussing the Benefits of INVOcell Presented at the 2021 American Society for Reproductive Medicine (ASRM) Congress & Expo
October 19, 2021
INVO Bioscience Announces Grand Opening of "Positib Fertility, an INVO Center" in Monterrey, Mexico on November 1, 2021
October 13, 2021
INVO Bioscience Announces $4.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
September 30, 2021
INVO Bioscience Advances INVOcell® Commercialization Efforts With Acquisition in Canada
September 8, 2021
INVO Bioscience Announces Official Opening of "Bloom Fertility, an INVO Center" in Atlanta
September 6, 2021
INVO Bioscience Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update
August 15, 2021
INVO Bioscience to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
August 4, 2021
INVO Bioscience Announces First Joint-Venture Grand Opening Scheduled for August 9, 2021 in Birmingham, Alabama
August 1, 2021
INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration
July 13, 2021
INVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an INVOcell Fertility Clinic in Atlanta
June 29, 2021
INVO Bioscience Appoints Andrea Goren as Chief Financial Officer
June 14, 2021
INVO Bioscience Reports First Quarter 2021 Financial and Operating Results and Provides Business Update
May 16, 2021
INVO Bioscience to Report First Quarter 2021 Financial Results on Monday, May 17, 2021
May 10, 2021
INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for Global Brand Expansion
May 9, 2021
INVO Bioscience Announces Appointment of Rebecca Messina to the Board of Directors
April 25, 2021
INVO Bioscience Signs Partnership Agreement with Lyfe Medical to Establish INVOcell Clinic in Northern California
April 18, 2021
INVO Bioscience Reports 2020 Financial Results
March 29, 2021
INVO Bioscience to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Tuesday, March 30, 2021
March 25, 2021
INVO Bioscience Achieves Key Milestone - Signs Agreement to Open First Joint Venture INVOcell Clinic in the United States
March 14, 2021
INVO Bioscience Expands Company-Owned Clinic Opportunity Under Amended U.S. Commercialization Agreement
March 7, 2021
INVO Bioscience Obtains Regulatory Approval to Import INVOcell Into Mexico
February 28, 2021
INVO Bioscience Advances Commercialization into the European Fertility Market with Initial Orders of INVOcell (IVC) in Spain
January 26, 2021
INVO Bioscience Expands Distribution of INVOcell Into the Pakistan Infertility Market with Galaxy Pharma Ltd.
January 14, 2021
INVO Bioscience and idsMED Group Enter Distribution Agreement for Malaysia
November 24, 2020
INVO Bioscience Reports Third Quarter 2020 Financial Results
November 15, 2020
INVO Bioscience Establishes Joint Venture to Operate Dedicated INVOcell Fertility Clinics in Mexico
September 29, 2020
INVO Bioscience Announces Appointment of Barbara Ryan and Matthew Szot to the Board of Directors
September 15, 2020
INVO Bioscience Reports Second Quarter 2020 Financial Results
August 12, 2020
INVO Bioscience Receives Registration Approval for INVOcell in Turkey
July 15, 2020
INVO Bioscience Announces Closing of Financing
June 28, 2020
INVO Bioscience Announces 1-for-20 Reverse Stock Split
May 21, 2020
INVO Bioscience Reports First Quarter 2020 Financial Results
May 14, 2020
INVO Bioscience Appoints Christopher Myer as VP Business Development - Americas
April 1, 2020
INVO Bioscience Reports 2019 Financial Results
March 29, 2020